With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The Food and Drug Administration (FDA) approved the use single-dose Xofluza (baloxavir marboxil) for patients ages 12 and over who are at high risk for influenza complications. Xofluza should only be administered to patients who have been symptomatic for 48 hours or less.
As the Southern Hemisphere nears the end of its typical flu season, influenza activity continues to decline, with a second wave of activity in Chile—mainly from influenza B—slowing, the World Health Organization (WHO) said in its latest global flu update.
Today the World Health Organization (WHO) dashboard shows 3 new Ebola cases in the Democratic Republic of the Congo (DRC), which raise the outbreak total to 3,194 cases, including 2,133 deaths. A total of 346 suspected cases are still under investigation.
Also today the DRC’s multisector Ebola committee (CMRE) said three cases yesterday originated in Kalunguta, Mambasa, and Mandima—all current virus hot spots.
The problem appears to be a mucus barrier that takes awhile to overcome.
A massive measles outbreak in the Democratic Republic of the Congo (DRC) accelerated again over the past few weeks, with spread to new areas, the World Health Organization (WHO) African regional office said yesterday in its weekly outbreaks and emergencies report.
California Governor Gavin Newsom yesterday signed two bills that limit medical exemptions for vaccines in schoolchildren.
Facebook yesterday announced the launch of new features to battle vaccine misinformation on Facebook and Instagram, a move that was applauded by the World Health Organization (WHO).
Researchers find no difference in health worker infections from flu, other viruses.
The group again voiced no preference to the flu shot or inhaled vaccine for kids.
Genentech, part of the Roche Group, yesterday announced promising phase 3 trial findings for the use of one-dose baloxavir marboxil (Xofluza) to safely treat flu in children, according to results presented on Sep 1 during the Options X Congress in Singapore.
